Glaukos (GKOS) director exercises 15K options and sells 15K shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GLAUKOS Corp director Aimee S. Weisner reported multiple equity transactions in company stock. She exercised a stock option for 15,000 shares of common stock at an exercise price of $24.69 per share, then reported open-market sales totaling 15,000 shares at weighted average prices between $115.69 and $118.56 across several trade blocks. She also reported bona fide gifts of 980 shares from her direct holdings and 980 shares transferred to the Saeman-Weisner Family Trust. After these transactions, she directly owned 18,806 shares and indirectly owned 29,505 shares through the Saeman-Weisner Family Trust, which includes 2,731 restricted stock units noted in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 15,000 shares ($1,760,761)
Net Sell
8 txns
Insider
WEISNER AIMEE S
Role
Director
Sold
15,000 shs ($1.76M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
| Gift | Common Stock | 980 | $0.00 | -- |
| Gift | Common Stock | 980 | $0.00 | -- |
| Exercise | Common Stock | 15,000 | $24.69 | $370K |
| Sale | Common Stock | 2,153 | $115.69 | $249K |
| Sale | Common Stock | 5,242 | $116.64 | $611K |
| Sale | Common Stock | 1,134 | $117.33 | $133K |
| Sale | Common Stock | 6,471 | $118.56 | $767K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 18,806 shares (Direct);
Common Stock — 29,505 shares (Indirect, Through the Saeman-Weisner Family Trust)
Footnotes (1)
- The transaction reflects shares transferred from the Reporting Person's direct ownership to the Saeman Weisner Family Trust. Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $115.01 to $116.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $116.10 to $117.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $117.12 to $118.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $118.18 to $118.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date.
FAQ
What insider transactions did GKOS director Aimee S. Weisner report?
Aimee S. Weisner reported exercising options for 15,000 Glaukos shares and selling 15,000 shares in multiple open-market trades. She also reported bona fide gifts totaling 1,960 shares, including a transfer involving the Saeman-Weisner Family Trust and changes in direct and indirect ownership.
What stock option exercise did the GKOS director disclose?
She disclosed exercising a stock option covering 15,000 Glaukos shares at an exercise price of $24.69 per share. The option was originally granted on June 2, 2016 and, according to the footnotes, fully vested on the first anniversary of the grant date before this exercise.
How do the footnotes clarify the GKOS director’s reported trades?
The footnotes explain that one gift transaction reflects a transfer from direct ownership to the Saeman-Weisner Family Trust and detail the vesting history of the option. They also specify that several sale trades were executed in multiple lots within stated price ranges, with weighted average prices disclosed.